71 related articles for article (PubMed ID: 1942580)
1. [A dramatic effect of continuous intra-arterial injected recombinant interleukin-2 immunotherapy on malignant hemangioendothelioma].
Takano M; Suzuki Y; Asai T; Masuzawa M; Nishiyama S
Nihon Hifuka Gakkai Zasshi; 1991 Jun; 101(7):719-25. PubMed ID: 1942580
[TBL] [Abstract][Full Text] [Related]
2. [A case of malignant hemangioendothelioma effectively treated with intra-arterial continuous infusion of interleukin-2].
Fujioka A; Sezai Y
Nihon Hifuka Gakkai Zasshi; 1991 Aug; 101(9):959-63. PubMed ID: 1942594
[TBL] [Abstract][Full Text] [Related]
3. [A case of malignant hemangioendothelioma effectively treated with intra-arterial continuous infusion of interleukin-2].
Fujioka A; Sugitani M; Suzuki Z; Tokita J; Yorimitsu K; Sezai Y
Gan To Kagaku Ryoho; 1991 Aug; 18(11):1958-61. PubMed ID: 1877838
[TBL] [Abstract][Full Text] [Related]
4. Angiosarcoma of the scalp treated with curative radiotherapy plus recombinant interleukin-2 immunotherapy.
Ohguri T; Imada H; Nomoto S; Yahara K; Hisaoka M; Hashimoto H; Tokura Y; Nakamura K; Shioyama Y; Honda H; Terashima H; Moroi Y; Furue M; Korogi Y
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1446-53. PubMed ID: 15817349
[TBL] [Abstract][Full Text] [Related]
5. [A case of Stewart-Treves syndrome--treatment with recombinant interleukin 2 and a review of Japanese literature].
Nabeya R; Kobayashi M; Fujita M; Yorifuji K; Eguchi N; Okamoto S
Nihon Hifuka Gakkai Zasshi; 1990 Sep; 100(10):1029-39. PubMed ID: 2266596
[TBL] [Abstract][Full Text] [Related]
6. [Successful immunotherapy of malignant hemangioendothelioma using recombinant interleukin-2].
Masuzawa M; Higashi K; Nishioka K; Nishiyama S
Nihon Hifuka Gakkai Zasshi; 1988 Mar; 98(3):367-9. PubMed ID: 3261813
[No Abstract] [Full Text] [Related]
7. A case of malignant haemangioendothelioma treated with recombinant interleukin-2.
Ansai S; Goto K; Aoki T; Hozumi Y; Aso K
Clin Exp Dermatol; 1993 Sep; 18(5):470-5. PubMed ID: 8252775
[TBL] [Abstract][Full Text] [Related]
8. Local/regional recombinant interleukin 2 (rIL-2) immunotherapy of tumors. Intra-arterial continuous infusion of rIL-2 in bladder cancer patients: a phase I study.
Velotti F; Tubaro A; Stoppacciaro A; Pettinato A; Morrone S; Bossola P; Napolitano T; Miano L; Ruco L; Piccoli M
Ann Ist Super Sanita; 1990; 26(3-4):411-21. PubMed ID: 2091503
[TBL] [Abstract][Full Text] [Related]
9. [Improved therapeutic effect of sequential immunotherapy with cyclophosphamide, large doses of OK-432 and recombinant interleukin-2 in breast cancer patients with disseminated metastatic liver tumors].
Akimoto M; Nishihira T; Hirakawa H; Abe M; Ohuchi N; Mori S; Kumagai K
Nihon Geka Gakkai Zasshi; 1991 Jan; 92(1):64-74. PubMed ID: 2014029
[TBL] [Abstract][Full Text] [Related]
10. [Continuous arterial infusion therapy of recombinant interleukin-2 and cyclophosphamide in hepatoma and liver metastasis].
Hayakawa K; Fukushima T; Seito D; Asakura Y; Yamanaka Y; Morita T; Sasaki M; Konn M; Ono K
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2842-4. PubMed ID: 2551226
[TBL] [Abstract][Full Text] [Related]
11. [Local immunotherapy of breast cancer: a case of advanced breast cancer improved by combined local injection therapy with OK-432 and rIL-2].
Fujimori M; Sugenoya A; Kobayashi S; Masuda H; Komatsu M; Takahashi S; Shimizu T; Tsuchiya S; Iida F
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2760-3. PubMed ID: 2551219
[TBL] [Abstract][Full Text] [Related]
12. [Clinical evaluation of local administration of RIL-2 in head and neck cancer].
Saito T; Kakiuti H; Kuki K; Yokota M; Jinnin T; Kimura T; Fujiwara K; Yoda J; Kunimoto M; Arai H
Nihon Jibiinkoka Gakkai Kaiho; 1989 Aug; 92(8):1265-70. PubMed ID: 2585201
[TBL] [Abstract][Full Text] [Related]
13. Treatment of eyelid lesion of angiosarcoma with facial artery recombinant interleukin-2 (rIL-2) injection.
Miura H; Asada Y
J Am Acad Dermatol; 2006 May; 54(5):907-8. PubMed ID: 16635681
[No Abstract] [Full Text] [Related]
14. [The efficacy of recombinant interleukin 2 in local treatment of superficial bladder tumors].
Fujioka T; Shiraishi M; Tanji S; Sato S; Koike H; Aoki H; Suzuki K; Kumagai K; Banya Y; Kubo T
Hinyokika Kiyo; 1988 Dec; 34(12):2115-9. PubMed ID: 3266444
[TBL] [Abstract][Full Text] [Related]
15. Preliminary experiences of intralesional immunotherapy in cutaneous metastatic melanoma.
Ridolfi L; Ridolfi R
Hepatogastroenterology; 2002; 49(44):335-9. PubMed ID: 11995445
[TBL] [Abstract][Full Text] [Related]
16. High-dose recombinant interleukin-2 in advanced cutaneous T-cell lymphoma.
Marolleau JP; Baccard M; Flageul B; Rybojad M; Laroche L; Vérola O; Brandely M; Morel P; Gisselbrecht C
Arch Dermatol; 1995 May; 131(5):574-9. PubMed ID: 7741545
[TBL] [Abstract][Full Text] [Related]
17. A case of malignant haemangioendothelioma showing response to interleukin 2 therapy.
Inadomi T; Fujioka A; Suzuki H
Br J Dermatol; 1992 Oct; 127(4):442-3. PubMed ID: 1419766
[No Abstract] [Full Text] [Related]
18. Malignant hemangioendothelioma.
Ihda H; Tokura Y; Fushimi M; Yokote R; Hashizume H; Shirahama S; Iwatsuki K; Murakami K; Takigawa M
Int J Dermatol; 1995 Nov; 34(11):811-6. PubMed ID: 8543420
[TBL] [Abstract][Full Text] [Related]
19. A first case of hepatic angiosarcoma treated with recombinant interleukin-2.
Mitsui F; Aikata H; Hashimoto Y; Nagaoki Y; Kimura Y; Katamura Y; Kawaoka T; Takaki S; Hiraga N; Tsuge M; Waki K; Hiramatsu A; Imamura M; Kawakami Y; Takahashi S; Arihiro K; Chayama K
Hiroshima J Med Sci; 2011 Dec; 60(4):91-6. PubMed ID: 22389954
[TBL] [Abstract][Full Text] [Related]
20. Malignant angioendothelioma--effect of immunotherapy with Corynebacterium parvum.
Tan SG; Cotterill JA; Roberts MM; Cunliffe WJ
Acta Derm Venereol; 1978; 58(6):551-3. PubMed ID: 83086
[No Abstract] [Full Text] [Related]
[Next] [New Search]
